Russian Institute of Nutrition Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2008
NCT00686816
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Russian Institue of Nutrition

Active Ingredients

Drugs in Phase 2 Trials (1)

olestra (Olean) (1 trial)

Drugs in Other Trials (1)

multivitamins (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Prediabetic State (Phase 2)

Weight Loss (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2